{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:27:28Z","timestamp":1772119648674,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T00:00:00Z","timestamp":1690502400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T00:00:00Z","timestamp":1690502400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-023-02820-0","type":"journal-article","created":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T03:02:07Z","timestamp":1690513327000},"page":"4171-4180","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of intravitreal ranibizumab and aflibercept for the treatment of diabetic macular edema: a real-world study"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5633-9036","authenticated-orcid":false,"given":"Puren","family":"Isik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3138-1507","authenticated-orcid":false,"given":"Selcuk","family":"Sizmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7448-451X","authenticated-orcid":false,"given":"Ebru","family":"Esen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6858-3423","authenticated-orcid":false,"given":"An\u0131l","family":"Uysal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8189-9246","authenticated-orcid":false,"given":"Nihal","family":"Demircan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,28]]},"reference":[{"key":"2820_CR1","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ajo.2016.09.002","volume":"172","author":"NV Patrao","year":"2016","unstructured":"Patrao NV, Antao S, Egan C, Omar A, Hamilton R et al (2016) Real-world outcomes of ranibizumab treatment for diabetic macular edema in a United Kingdom National Health Service Setting. Am J Ophthalmol 172:51\u201357. https:\/\/doi.org\/10.1016\/j.ajo.2016.09.002","journal-title":"Am J Ophthalmol"},{"key":"2820_CR2","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00417-008-0960-y","volume":"247","author":"E Davidov","year":"2009","unstructured":"Davidov E, Breitscheidel L, Clouth J, Reips M, Happich M (2009) Diabetic retinopathy and health-related quality of life. Graefes Arch Clin Exp Ophthalmol 247:267\u2013272. https:\/\/doi.org\/10.1007\/s00417-008-0960-y","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2820_CR3","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1185\/03007995.2010.482503","volume":"26","author":"E Chen","year":"2010","unstructured":"Chen E, Looman M, Laouri M et al (2010) Burden of illness of diabetic macular edema: literature review. Curr med Res Opin 26:587\u20131597. https:\/\/doi.org\/10.1185\/03007995.2010.482503","journal-title":"Curr med Res Opin"},{"issue":"4","key":"2820_CR4","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.ophtha.2011.12.039","volume":"119","author":"Nguyen QD, Brown DM, Marcus DM, Boyer DS, Patel S, Feiner L, Gibson A, Sy J, Rundle AC, Hopkins JJ, Rubio RG, Ehrlich JS; RISE and RIDE Research Group","year":"2012","unstructured":"Nguyen QD, Brown DM, Marcus DM, Boyer DS, Patel S, Feiner L, Gibson A, Sy J, Rundle AC, Hopkins JJ, Rubio RG, Ehrlich JS; RISE and RIDE Research Group (2012) Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology 119(4):789\u2013801. https:\/\/doi.org\/10.1016\/j.ophtha.2011.12.039","journal-title":"Ophthalmology"},{"issue":"4","key":"2820_CR5","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.ophtha.2011.01.031","volume":"118","author":"P Mitchell","year":"2011","unstructured":"Mitchell P, Bandello F, Schmidt-Erfurth U, Lang GE, Massin P, Schlingemann RO et al (2011) The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology 118(4):615\u2013625. https:\/\/doi.org\/10.1016\/j.ophtha.2011.01.031","journal-title":"Ophthalmology"},{"issue":"10","key":"2820_CR6","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1016\/j.ophtha.2015.06.017","volume":"122","author":"DM Brown","year":"2015","unstructured":"Brown DM, Schmidt-Erfurth U, Do DV, Holz FG, Boyer DS, Midena E et al (2015) Intravitreal aflibercept for diabetic macular edema: 100-week results from the VISTA and VIVID studies. Ophthalmology 122(10):2044\u20132052. https:\/\/doi.org\/10.1016\/j.ophtha.2015.06.017","journal-title":"Ophthalmology"},{"issue":"13","key":"2820_CR7","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1056\/NEJMoa1414264","volume":"372","author":"JA Wells","year":"2015","unstructured":"Diabetic Retinopathy Clinical Research Network, Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP et al (2015) Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med 372(13):1193\u20131203. https:\/\/doi.org\/10.1056\/NEJMoa1414264","journal-title":"N Engl J Med"},{"key":"2820_CR8","doi-asserted-by":"publisher","unstructured":"Brown DM, Nguyen QD, Marcus DM, Boyer DS, Patel S et al, RIDE and RISE Research Group (2013) Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE. Ophthalmology 120(10):2013\u20132022. https:\/\/doi.org\/10.1016\/j.ophtha.2013.02.034","DOI":"10.1016\/j.ophtha.2013.02.034"},{"issue":"6","key":"2820_CR9","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.ophtha.2016.02.022","volume":"123","author":"JA Wells","year":"2016","unstructured":"Wells JA, Glassman AR, Ayala AR et al (2016) Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema: two-year results from a comparative effectiveness randomized clinical trial. Ophthalmology 123(6):1351\u20131359. https:\/\/doi.org\/10.1016\/j.ophtha.2016.02.022","journal-title":"Ophthalmology"},{"key":"2820_CR10","doi-asserted-by":"publisher","first-page":"393","DOI":"10.2147\/OPTH.S128509","volume":"11","author":"KJ Blinder","year":"2017","unstructured":"Blinder KJ, Dugel PU, Chen S et al (2017) Anti-VEGF treatment of diabetic macular edema in clinical practice: effectiveness and patterns of use (ECHO Study Report 1). Clin Ophthalmol 11:393\u2013401. https:\/\/doi.org\/10.2147\/OPTH.S128509","journal-title":"Clin Ophthalmol"},{"issue":"12","key":"2820_CR11","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.oret.2018.06.004","volume":"2","author":"T Ciulla","year":"2018","unstructured":"Ciulla T, Bracha P, Pollack J, Williams D (2018) Real-world outcomes of anti-vascular endothelial growth factor therapy in diabetic macular edema in the United States. Ophthalmol Retina 2(12):1179\u20131187. https:\/\/doi.org\/10.1016\/j.oret.2018.06.004","journal-title":"Ophthalmol Retina"},{"key":"2820_CR12","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S0161-6420(13)38014-2","volume":"98","author":"Early Treatment Diabetic Retinopathy Study Research Group","year":"1991","unstructured":"Early Treatment Diabetic Retinopathy Study Research Group (1991) Fundus photographic risk factors for progression of diabetic retinopathy: ETDRS report number 12. Ophthalmology 98:823\u2013833","journal-title":"Ophthalmology"},{"issue":"6","key":"2820_CR13","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s00417-020-04640-9","volume":"258","author":"S Arf","year":"2020","unstructured":"Arf S, Muslubas IS, Hocaoglu M, Ersoz MG, Ozdemir H, Karacorlu M (2020) Spectral domain optical coherence tomography classification of diabetic macular edema: a new proposal to clinical practice. Graefes Arch Clin Exp Ophthalmol 258(6):1165\u20131172. https:\/\/doi.org\/10.1007\/s00417-020-04640-9","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"2820_CR14","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ajo.2007.09.029","volume":"145","author":"D Gaucher","year":"2008","unstructured":"Gaucher D, Sebah C, Erginay A et al (2008) Optical coherence tomography features during the evaluation of serous retinal detachment in patients with diabetic macular edema. Am J Ophthalmol 145(2):289\u2013296. https:\/\/doi.org\/10.1016\/j.ajo.2007.09.029","journal-title":"Am J Ophthalmol"},{"key":"2820_CR15","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1016\/j.ophtha.2013.07.042","volume":"120","author":"JS Duker","year":"2013","unstructured":"Duker JS, Kaiser PK, Binder S et al (2013) The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology 120:2611\u20132619. https:\/\/doi.org\/10.1016\/j.ophtha.2013.07.042","journal-title":"Ophthalmology"},{"key":"2820_CR16","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/s0002-9394(00)00661-9","volume":"131","author":"T Otani","year":"2001","unstructured":"Otani T, Kishi S (2001) Tomographic findings of foveal hard exudates in diabetic macular edema. Am J Ophthalmol 131:50\u201354. https:\/\/doi.org\/10.1016\/s0002-9394(00)00661-9","journal-title":"Am J Ophthalmol"},{"key":"2820_CR17","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1097\/IAE.0b013e3181d87e04","volume":"30","author":"NZ Gregori","year":"2010","unstructured":"Gregori NZ, Feuer W, Rosenfeld PJ (2010) Novel method for analyzing snellen visual acuity measurements. Retina 30:1046\u20131050. https:\/\/doi.org\/10.1097\/IAE.0b013e3181d87e04","journal-title":"Retina"},{"key":"2820_CR18","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1016\/j.ophtha.2012.02.010","volume":"119","author":"DV Do","year":"2012","unstructured":"Do DV, Nguyen QD, Boyer D et al (2012) One-year outcomes of the DA VINCI study of VEGF trap-eye in eyes with diabetic macular edema. Ophthalmology 119:1658\u20131665. https:\/\/doi.org\/10.1016\/j.ophtha.2012.02.010","journal-title":"Ophthalmology"},{"issue":"10","key":"2820_CR19","doi-asserted-by":"publisher","first-page":"541","DOI":"10.2147\/OPTH.S90913","volume":"29","author":"AC Pedrosa","year":"2016","unstructured":"Pedrosa AC, Reis-Silva A, Pinheiro-Costa J et al (2016) Treatment of neovascular age-related macular degeneration with anti-VEGF agents: retrospective analysis of 5-year outcomes. Clin Ophthalmol 29(10):541\u2013546. https:\/\/doi.org\/10.2147\/OPTH.S90913","journal-title":"Clin Ophthalmol"},{"issue":"5","key":"2820_CR20","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.ophtha.2013.11.031","volume":"121","author":"Writing Committee for the UK Age-Related Macular Degeneration EMR Users Group","year":"2014","unstructured":"Writing Committee for the UK Age-Related Macular Degeneration EMR Users Group (2014) The Neovascular Age-Related Macular Degeneration Database: multicenter study of 92976 ranibizumab injections. Report 1\u2014visual acuity. Ophthalmology 121(5):1092\u20131101. https:\/\/doi.org\/10.1016\/j.ophtha.2013.11.031","journal-title":"Ophthalmology"},{"issue":"4","key":"2820_CR21","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1159\/000495623","volume":"241","author":"P Shwarzer","year":"2019","unstructured":"Shwarzer P, Ebneter A, Munk M, Wolf S, Zinkernagel MS (2019) One-year results of using a treat-and-extend regimen without a loading phase with anti-VEGF agents in patients with treatment-naive diabetic macular edema. Ophtalmologica 241(4):220\u2013225. https:\/\/doi.org\/10.1159\/000495623","journal-title":"Ophtalmologica"},{"issue":"9","key":"2820_CR22","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.3390\/jcm9092848","volume":"9","author":"S Chujo","year":"2020","unstructured":"Chujo S, Sugimoto M, Sasaki T et al (2020) Comparison of 2-year outcomes between intravitreal ranibizumab and intravitreal aflibercept for diabetic macular edema with \u201cTreat-and-Extend\u201d regimen\u2014Its usefulness and problems. J Clin Med 9(9):2848. https:\/\/doi.org\/10.3390\/jcm9092848","journal-title":"J Clin Med"},{"key":"2820_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0223793","author":"P Plaza-Ramos","year":"2019","unstructured":"Plaza-Ramos P, Borque E, Garc\u0131\u00b4a-Layana (2019) A Evaluation of ranibizumab and aflibercept for the treatment of diabetic macular edema in daily clinical practice. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0223793","journal-title":"PLoS ONE"},{"issue":"2","key":"2820_CR24","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10456-011-9249-6","volume":"15","author":"N Papadopoulos","year":"2012","unstructured":"Papadopoulos N, Martin J, Ruan Q et al (2012) Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab. Angiogenesis 15(2):171\u2013185. https:\/\/doi.org\/10.1007\/s10456-011-9249-6","journal-title":"Angiogenesis"},{"issue":"9","key":"2820_CR25","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1136\/2Fbjophthalmol-2011-300654","volume":"96","author":"MW Stewart","year":"2012","unstructured":"Stewart MW (2012) Aflibercept (VEGF Trap-eye): the newest anti-VEGF drug. Br J Ophthalmol 96(9):1157\u20131158. https:\/\/doi.org\/10.1136\/2Fbjophthalmol-2011-300654","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"2820_CR26","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1016\/j.ophtha.2015.02.006","volume":"122","author":"T Ishibashi","year":"2015","unstructured":"Ishibashi T, Li X, Koh A et al (2015) The REVEAL study: ranibizumab monotherapy or combined with laser versus laser monotherapy in Asian patients with diabetic macular edema. Ophthalmology 122(7):1402\u20131415. https:\/\/doi.org\/10.1016\/j.ophtha.2015.02.006","journal-title":"Ophthalmology"},{"key":"2820_CR27","doi-asserted-by":"publisher","first-page":"2407037","DOI":"10.1155\/2017\/2407037","volume":"2017","author":"LN Distefano","year":"2017","unstructured":"Distefano LN, Garcia-Arumi J, Castillo M et al (2017) Combination of anti-VEGF and laser photocoagulation for diabetic macular edema: a review. J Ophthalmol 2017:2407037. https:\/\/doi.org\/10.1155\/2017\/2407037","journal-title":"J Ophthalmol"},{"key":"2820_CR28","doi-asserted-by":"publisher","first-page":"1747108","DOI":"10.1155\/2017\/1747108","volume":"2017","author":"N Shimizu","year":"2017","unstructured":"Shimizu N, Oshitari T, Tatsumi T et al (2017) Comparisons of efficacy of intravitreal aflibercept and ranibizumab in eyes with diabetic macular edema. Biomed Res Int 2017:1747108. https:\/\/doi.org\/10.1155\/2017\/1747108","journal-title":"Biomed Res Int"},{"issue":"6","key":"2820_CR29","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/eye.2013.17","volume":"27","author":"A Koytak","year":"2013","unstructured":"Koytak A, Altinisik M, Sogutlu Sari E et al (2013) Effect of a single intravitreal bevacizumab injection on different optical coherence tomographic patterns of diabetic macular oedema. Eye (London) 27(6):716\u2013721. https:\/\/doi.org\/10.1038\/eye.2013.17","journal-title":"Eye (London)"},{"key":"2820_CR30","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.2147\/OPTH.S37340","volume":"6","author":"M Soman","year":"2012","unstructured":"Soman M, Ganekal S, Nair RU et al (2012) Effect of panretinal photocoagulation on macular morphology and thickness in eyes with proliferative diabetic retinopathy without clinically significant macular edema. Clin Ophthalmol 6:2013\u20132017. https:\/\/doi.org\/10.2147\/OPTH.S37340","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"2820_CR31","doi-asserted-by":"publisher","first-page":"81","DOI":"10.18240\/ijo.2016.01.14","volume":"9","author":"XY Chen","year":"2016","unstructured":"Chen XY, Song WJ, Cai HY, Zhao L (2016) Macular edema after cataract surgery in diabetic eyes evaluated by optical coherence tomography. Int J Ophthalmol 9(1):81\u201385. https:\/\/doi.org\/10.18240\/ijo.2016.01.14","journal-title":"Int J Ophthalmol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-023-02820-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-023-02820-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-023-02820-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T07:10:08Z","timestamp":1695625808000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-023-02820-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,28]]},"references-count":31,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["2820"],"URL":"https:\/\/doi.org\/10.1007\/s10792-023-02820-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1076981\/v1","asserted-by":"object"}]},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,28]]},"assertion":[{"value":"13 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Cukurova University Board of Clinical Research and Ethics (22 January 2021, 107\/30). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}